These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 8929320)

  • 1. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.
    Rigo P; Paulus P; Kaschten BJ; Hustinx R; Bury T; Jerusalem G; Benoit T; Foidart-Willems J
    Eur J Nucl Med; 1996 Dec; 23(12):1641-74. PubMed ID: 8929320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does fluorine-18 fluorodeoxyglucose metabolic imaging of tumours benefit oncology?
    Brock CS; Meikle SR; Price P
    Eur J Nucl Med; 1997 Jun; 24(6):691-705. PubMed ID: 9169580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis of cancers by FDG-PET].
    Ichiya Y
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):7-10. PubMed ID: 9091463
    [No Abstract]   [Full Text] [Related]  

  • 4. PET and [18F]-FDG in oncology: a clinical update.
    Conti PS; Lilien DL; Hawley K; Keppler J; Grafton ST; Bading JR
    Nucl Med Biol; 1996 Aug; 23(6):717-35. PubMed ID: 8940714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients.
    Strauss LG
    Eur J Nucl Med; 1996 Oct; 23(10):1409-15. PubMed ID: 8781149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET cancer evaluations with FDG.
    Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
    J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorodeoxyglucose (FDG) and tumour metabolism.
    Van Wyngaarden KE; Pauwels EK
    Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
    [No Abstract]   [Full Text] [Related]  

  • 8. PET FDG studies in oncology.
    Hawkins RA; Hoh CK
    Nucl Med Biol; 1994 Jul; 21(5):739-47. PubMed ID: 9241650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of positron-emission tomography in oncology].
    Strauss LG; Kabelitz D; Kremer B; Lode H; Meinertz T; Sauerbruch T; Sterry W
    Dtsch Med Wochenschr; 1996 Feb; 121(7):207-9. PubMed ID: 8681765
    [No Abstract]   [Full Text] [Related]  

  • 10. Positron emission tomography in oncology.
    Leskinen-Kallio S
    Clin Physiol; 1994 May; 14(3):329-35. PubMed ID: 8026150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [FDG-PET in oncology. Methodological principles and clinical applications].
    Kletter K; Becherer A
    Radiologe; 1999 Jul; 39(7):600-9. PubMed ID: 10472089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: a preliminary report.
    Liu RS; Yeh SH; Huang MH; Wang LS; Chu LS; Chang CP; Chu YK; Wu LC
    Eur J Nucl Med; 1995 Dec; 22(12):1402-7. PubMed ID: 8586085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer diagnosis with positron emission tomography (PET)].
    Kubota K
    Kaku Igaku; 1996 Feb; 33(2):207-12. PubMed ID: 8721109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer treatment monitoring with fluorine-18 2-fluoro-2-deoxy-D-glucose and positron emission tomography: frustration or future.
    Minn H; Paul R
    Eur J Nucl Med; 1992; 19(11):921-4. PubMed ID: 1425778
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron emission tomographic oncology.
    Lawson MA
    West J Med; 1994 Oct; 161(4):411-2. PubMed ID: 7817554
    [No Abstract]   [Full Text] [Related]  

  • 16. Positron emission tomography in oncology. General acceptance of its role is overdue.
    Lamki LM
    Cancer; 1996 Nov; 78(10):2039-42. PubMed ID: 8918394
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there a future for PET in oncology?
    Price P
    Eur J Nucl Med; 1997 Jun; 24(6):587-9. PubMed ID: 9235296
    [No Abstract]   [Full Text] [Related]  

  • 18. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism.
    Melon P; Luxen A; Hamoir E; Meurisse M
    Eur J Nucl Med; 1995 Jun; 22(6):556-8. PubMed ID: 7556303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose.
    Martin WH; Delbeke D; Patton JA; Sandler MP
    Radiology; 1996 Jan; 198(1):225-31. PubMed ID: 8539384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography.
    Bury T; Dowlati A; Paulus P; Hustinx R; Radermecker M; Rigo P
    Eur J Nucl Med; 1996 Feb; 23(2):204-6. PubMed ID: 8925857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.